SABBY 13G ORMP 7.03.18

Company

ORAMED PHARMACEUTICALS INC.

Filed

July 3, 2018

Accession Number

0001535610-18-000095

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →